Please assess the completion status of the following clinical trial:

Trial Title: Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Receive a minimum of four mental health treatment sessions from the SOPP that span at least a 1-month interval~* SOPP treatment plan must indicate intent to deliver ongoing PTSD care for at least 1 year, including visits at least once per month~* Diagnosis of PTSD resulting from military trauma using DSM-IV criteria~* Current nicotine use, smoking greater at least 10 cigarettes per day for at least 16 of the past 30 days prior to randomization~* Demonstrated motivation to quit smoking~Exclusion Criteria:~* Use of smokeless tobacco or smoke pipes or cigars~* Any psychotic disorder that is not in remission~* Bipolar disorder that is not in remission~* Any substance dependence disorder that is not in remission (current substance abuse disorder and substance dependence disorder in remission for more than 1 month are not exclusions)~* Imminent risk for suicide or violence, as determined during routine assessment by SOPP clinical staff~* Severe psychiatric symptoms or psychosocial instability likely to prevent participation in the study protocol (i.e., attendance at scheduled sessions, ability to read study materials, and/or ability to comprehend interventions), as determined during routine assessment by SOPP clinical staff~* Gross impairment from organic mental disorder, as determined during routine assessment by SOPP clinical staff

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): Integration of smoking cessation therapy with PTSD therapy.
- Arm 2 (Type: ACTIVE_COMPARATOR): Per standard of care, patients are referred to a smoking cessation clinic for their smoking cessation therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).